Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 415

Foursquare to fuse with Factual

Naver, Simon Property and O’Reilly Media-backed Foursquare is joining forces with peer Factual to create the world's biggest location intelligence provider.

Apr 8, 2020

WorkJam packs $50m into series C

The employee management software provider closed a series C round featuring all its existing investors, which include Novel TMT Ventures.

Apr 8, 2020

FCC digs in for District Ventures Capital fund

Farm Credit Canada provided more than a third of the capital as food and beverage-focused District Ventures Capital closed its fund at $70.8m.

Apr 7, 2020

Airbnb adds $1bn in new round

Silver Lake and Sixth Street Partners supplied debt and equity financing for the Alphabet-backed online short-term accommodation platform at a $26bn valuation.

Apr 7, 2020

PsiQuantum processes $215m

M12 participated in a round for University of Bristol spinout PsiQuantum, which is developing a quantum computer system.

Apr 7, 2020

Click Diagnostics picks up $70m

Cedars-Sinai Medical Center contributed to a round for the stealth-stage diagnostics technology developer, which raised $101m less than a year ago.

Apr 7, 2020

Zentalis zips to $165m IPO

The Pharamron-backed oncology drug developer floated at the top of its range while increasing the number of shares in the offering.

Apr 6, 2020

Apple anticipates $100m NextVR acquisition

NetEase, SoftBank, Time Warner, Madison Square Garden, Dick Clark Productions, Citic Guoan, Founder Group and Comcast could all exit the virtual event platform developer.

Apr 6, 2020

Axa lends help to $15m Lessonly round

The online training platform developer increased its overall funding to more than $29m with a series C round led by Axa Venture Partners.

Apr 6, 2020

VenBio visits corporates for $394m third fund

Undisclosed pharmaceutical companies were among the investors in the venture firm's third fund, which will target biopharmaceutical developers.

Apr 6, 2020
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here